KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash from Investing Activities (2023 - 2025)

Biocryst Pharmaceuticals' Cash from Investing Activities history spans 9 years, with the latest figure at -$83.5 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 569.11% year-over-year to -$83.5 million; the TTM value through Dec 2025 reached -$13.7 million, down 126.04%, while the annual FY2025 figure was -$13.7 million, 126.04% down from the prior year.
  • Cash from Investing Activities reached -$83.5 million in Q4 2025 per BCRX's latest filing, down from $13.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $29.1 million in Q2 2025 to a low of -$107.1 million in Q1 2023.
  • Average Cash from Investing Activities over 3 years is -$7.7 million, with a median of $11.0 million recorded in 2024.
  • The largest YoY upside for Cash from Investing Activities was 1289.34% in 2025 against a maximum downside of 569.11% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at -$28.5 million in 2023, then soared by 162.5% to $17.8 million in 2024, then tumbled by 569.11% to -$83.5 million in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Cash from Investing Activities are -$83.5 million (Q4 2025), $13.6 million (Q3 2025), and $29.1 million (Q2 2025).